내시경전 항혈소판제, 항응고제 언제 끊어야 하나?

 

내시경전 항혈소판제, 항응고제 언제 끊어야 하나?

 

해리슨 19판 자료

 

 

Low-risk endoscopic procedures

: EGD, CFS with/without biopsy, EUS without FNA, ERCP with stent exchange

 

High-risk endoscopic procedures

: EGD or CFS with dilatation, polypectomy, thermal ablation, PEG, EUS with FNA, ERCP with sphincterotomy or pseudocyst drainage.

 

High-risk for thromboembolism (warfarin 중단 시 Heparin briding therapy 고려)

: MVR, AVR with other risk factors

  - Non-valvular a. fib with a hx. of smoke, embolic event, cardiac thrombus, or CHADS2 score >= 4 points

  -  VTE within the past 3 months or severe underlying thrombophilia

 

 

* 관련 포스팅 :

2019/01/08 - [핵심요약] 소화기내과 (2)

2019/01/08 - [핵심요약] 소화기내과 (1)

2018/08/09 - 침습적인 시술에 앞서 항응고제는 어떻게 해야할까?

 

 

끝.

2019. 5. 3 - SJH

댓글(0)

Designed by JB FACTORY